James H. Sabry, Director at CYTOKINETICS INC (CYTK), sold 13,400 shares at $2.75 ($37K) on 2009-08-17, disclosed to the SEC on 2009-08-19.
Open-market sale of $37k CYTK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.73 | 330 | $901 | 2.4% |
| 2 | $2.74 | 1,370 | $4K | 10.1% |
| 3 | $2.75 | 3,300 | $9K | 24.5% |
| 4 | $2.76 | 1,800 | $5K | 13.4% |
| 5 | $2.77 | 2,700 | $7K | 20.2% |
| 6 | $2.78 | 2,600 |
| $7K |
| 19.5% |
| 7 | $2.79 | 1,300 | $4K | 9.8% |
| Total | $2.76 avg | 13,400 | $37K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |